focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,693.00
Bid: 4,692.00
Ask: 4,696.00
Change: -33.00 (-0.70%)
Spread: 4.00 (0.085%)
Open: 4,691.00
High: 4,717.00
Low: 4,673.00
Prev. Close: 4,726.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

24 Mar 2023 10:31

RNS Number : 1733U
Croda International PLC
24 March 2023
 

24 March 2023

 

Croda International Plc

 

 

Appointment of Non-Executive Director

 

The Board of Croda International Plc is pleased to announce the appointment of Chris Good as non-executive director. Chris will join the Board with effect from 27 April 2023.

 

Chris has spent his career in the consumer care industry. He recently retired following more than 20 years at Estee Lauder Companies, a global leader in prestige beauty, with the last five years of his executive career as Group President of North America (Estee Lauder Companies' home market) with responsibility for over 25 brands. Chris was also a member of Estee Lauder Companies' Executive Committee.

 

Prior to joining Estee Lauder Companies, Chris spent over 10 years at Unilever in senior marketing, executive and general management roles across Europe, North America and Asia.

 

On joining the Croda Board, Chris will also be appointed to the Audit, Nomination and Remuneration Committees. 

 

Anita Frew, Chair of Croda International Plc, said,

 

"I am delighted to welcome Chris to the Croda Board.

 

Chris' deep understanding of the consumer care industry and in particular his insights into beauty care markets and consumers will be of great value to Croda and the Board. As well as having significant P&L experience, Chris also brings a truly international perspective to the Board, having lived and worked in the USA, Switzerland, Japan, Singapore, Russia and the UK with region wide responsibilities for EMEA, APAC and North America during his successful executive career.

 

His appointment strengthens the consumer care knowledge and experience we have around the Board table, which will support our continued transition to a pure play Consumer Care and Life Sciences business."

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZFGDGGFZM
Date   Source Headline
28th Mar 201812:19 pmRNSScheme of Arrangement becomes Effective
26th Mar 201812:09 pmRNSDirector/PDMR Shareholding - Replacement
22nd Mar 20182:41 pmRNSDirector/PDMR Shareholding
21st Mar 20183:16 pmRNSDirector/PDMR Shareholding
21st Mar 20182:56 pmRNSDirector/PDMR Shareholding
19th Mar 20185:45 pmRNSAnnual Financial Report
16th Mar 20181:47 pmRNSDirector/PDMR Shareholding
13th Mar 20182:18 pmRNSDirector/PDMR Shareholding
12th Mar 20182:03 pmRNSDirector/PDMR Shareholding
8th Mar 201811:20 amRNSDirector/PDMR Shareholding
8th Mar 201811:19 amRNSDirector/PDMR Shareholding
8th Mar 201811:18 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:16 amRNSDirector/PDMR Shareholding
8th Mar 201811:15 amRNSDirector/PDMR Shareholding
8th Mar 201811:13 amRNSDirector/PDMR Shareholding
8th Mar 201811:10 amRNSDirector/PDMR Shareholding
8th Mar 201811:08 amRNSDirector/PDMR Shareholding
2nd Mar 20184:41 pmRNSTransaction in Own Shares
28th Feb 201810:19 amRNSReplacement:Results for the year ended 31 Dec 2017
27th Feb 20187:00 amRNSDirectorate Change
27th Feb 20187:00 amRNSResults for the year ended 31 December 2017
26th Feb 20183:34 pmRNSPublication of Scheme Document
26th Feb 20189:08 amRNSForm 8 (OPD) PLANT IMPACT PLC
16th Feb 20187:00 amRNSRecommended cash offer
15th Feb 20185:14 pmRNSDirector/PDMR Shareholding
13th Feb 20184:51 pmRNSDirector/PDMR Shareholding
11th Jan 20184:47 pmRNSDirector/PDMR Shareholding
11th Jan 20181:00 pmRNSTechnology acquisitions
12th Dec 20172:23 pmRNSDirector/PDMR Shareholding
13th Nov 20174:01 pmRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSTrading Update for the Third Quarter 2017
17th Oct 20179:23 amRNSAppointment of KPMG LLP as External Auditor
11th Oct 20174:59 pmRNSDirector/PDMR Shareholding
4th Oct 20172:36 pmRNSDirector/PDMR Shareholding
14th Sep 20171:50 pmRNSDirector/PDMR Shareholding
12th Sep 20172:17 pmRNSDirector/PDMR Shareholding
11th Aug 20172:20 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSResults for the six months ended 30 June 2017
11th Jul 20174:22 pmRNSDirector/PDMR Shareholding
11th Jul 20173:26 pmRNSDirector/PDMR Shareholding
14th Jun 20172:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20175:45 pmRNSDirector/PDMR Shareholding
22nd May 20173:35 pmRNSHolding(s) in Company
19th May 20174:34 pmRNSHolding(s) in Company
18th May 20174:27 pmRNSHolding(s) in Company
15th May 20176:01 pmRNSHolding(s) in Company
15th May 20175:46 pmRNSDirector/PDMR Shareholding
15th May 20175:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.